Orthocell jumps as nerve repair tech shows hope for erectile dysfunction post-prostate surgery
Orthocell shares popped +10% as the company reported its flagship nerve repair product, Remplir, is being used by Australian urologists.
Currently unlisted.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
OTC | move over to new name | 26/11/16 | 0 | 2.5K | |||
|
|||||||
OTC | Ann: AGM Presentation | 24/11/16 | 3 | 3.1K | |||
|
|||||||
OTC | Ann: Results of Annual General Meeting | 23/11/16 | 0 | 859 | |||
|
|||||||
OTC | Ann: OTOC Acquires Survey & Spatial Engineering Business | 23/11/16 | 3 | 2.3K | |||
|
|||||||
OTC | Ann: Notice of Annual General Meeting/Proxy Form-OTC.AX | 22/11/16 | 1 | 1.0K | |||
|
|||||||
OTC | News: OTC OTOC acquires survey & spatial engineering business | 21/11/16 | 0 | 756 | |||
|
|||||||
OTC | Ann: FY2016 Results Presentation-OTC.AX | 15/11/16 | 15 | 8.9K | |||
|
|||||||
OTC | News: OTC Otoc Ltd announces award of contract to upgrade BHP Billiton Village Entertainment Systems | 14/11/16 | 0 | 693 | |||
|
See All Discussions